PRCT
PROCEPT BioRobotics Corp
$28.35
+1.87%
$1.6B
No data for this timeframe.
Vol
Market Cap$1.6B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (71%)
Inst. Holders9 funds
Inst. Value$382.4M
Inst. Activity4 buys / 1 sells
Insider Activity3B / 6S
Insider Net $$6.7M
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001588978·Prev Close $27.83
Recent Activity
Jun 8, 2026
short_volume
Short Volume: PRCT — 68.4% short (0.4M / 0.6M)
Short: 387,740 | Exempt: 1 | TRF Vol: 567,279 | Short Ratio: 68.4% | Off-exchange volume (dark pool
Mar 19, 2026
SEC
EVP and CFO Kevin Waters sold $19,876 worth of PRCT shares in a single open-market transaction. The sale is small in abs
CLUSTER — Impact 2/10
Mar 19, 2026
Insider
Nouri Alaleh sold 3,031 shares
EVP, CLO, CORP. SEC. @ $25.82 ($78.3K)
Mar 17, 2026
Insider
Nouri Alaleh sold 304 shares
EVP, CLO, CORP. SEC. @ $28.15 ($8.6K)
Mar 17, 2026
Insider
Waters Kevin sold 706 shares
EVP, CFO @ $28.15 ($19.9K)
Mar 12, 2026
SEC
Over the past week, two executives at PROCEPT BioRobotics sold shares totaling approximately $323,000, while a director,
CLUSTER — Impact 7/10
Mar 9, 2026
SEC
A significant insider trading cluster at PRCT shows substantial open-market buying by director Desai Antal Rohit, totali
CLUSTER — Impact 7/10
Inst.
FMR LLC — TRIM
4,653,111 shares ($146.4M)
Price Targets
$30.44
+5.8% upside
Buy
Current $28.78
Low $20.00
Median $31.00
High $37.00
9 analysts
$20.00
$37.00
Analyst Ratings
5Strong Buy
10Buy
5Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 30, 2026 | Piper Sandler | REITERATE | Overweight → Overweight |
| Mar 6, 2026 | Baird | INITIATE | Neutral |
| Mar 2, 2026 | Truist Securities | MAINTAIN | Buy → Buy |
| Feb 26, 2026 | Leerink Partners | MAINTAIN | Outperform → Outperform |
| Feb 26, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.46 ▼ -1.6% | $-0.49 — $-0.36 | -30% YoY | 10 |
| Next Q | $-0.34 | $-0.40 — $-0.30 | 12% YoY | 10 |
| Current FY | $-1.52 | $-1.61 — $-1.43 | 12% YoY | 10 |
| Next FY | $-0.87 ▼ -3.2% | $-1.23 — $-0.56 | 43% YoY | 10 |
Latest Reports
NEUTRAL
CLUSTER
2/10
EVP and CFO Kevin Waters sold $19,876 worth of PRCT shares in a single open-market transaction. The sale is small in abs
Mar 19, 2026
BULLISH
CLUSTER
7/10
Over the past week, two executives at PROCEPT BioRobotics sold shares totaling approximately $323,000, while a director,
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $163.7M | — |
| FMR LLC | $146.4M | TRIM |
| MORGAN STANLEY | $26.5M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $14.5M | NEW |
| BANK OF AMERICA CORP | $13.6M | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 19, 2026 | Nouri Alaleh | SELL | $78.3K |
| Mar 17, 2026 | Nouri Alaleh | SELL | $8.6K |
| Mar 17, 2026 | Waters Kevin | SELL | $19.9K |
| Mar 10, 2026 | Nouri Alaleh | SELL | $79.3K |
| Mar 9, 2026 | Desai Antal | BUY | $1.0M |
9 institutional holders with $382.4M total value (12,156,447 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN. Net buying activity: 4 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 5,202,306 | $163.7M | 42.8% | — |
| 2 | FMR LLC | 4,653,111 | $146.4M | 38.3% | TRIM -42.1% |
| 3 | MORGAN STANLEY | 843,491 | $26.5M | 6.9% | ADD +46.4% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 462,373 | $14.5M | 3.8% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 431,205 | $13.6M | 3.5% | TRIM -35.4% |
| 6 | TWO SIGMA INVESTMENTS, LP | 266,476 | $8.4M | 2.2% | ADD +84.8% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 117,466 | $3.7M | 1.0% | NEW |
| 8 | WELLS FARGO & COMPANY/MN | 93,861 | $3.0M | 0.8% | ADD +34.7% |
| 9 | NORGES BANK | 86,158 | $2.7M | 0.7% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | TRIM | 8,036,055 | 4,653,111 | -42.1% | $146.4M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 144,181 | 266,476 | +84.8% | $8.4M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 117,466 | — | $3.7M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 69,658 | 93,861 | +34.7% | $3.0M | 2025-Q4 |
| NORGES BANK | NEW | — | 86,158 | — | $2.7M | 2025-Q4 |
| UBS Group AG | DOUBLED | 412,015 | 944,545 | +129.3% | $33.7M | 2025-Q3 |
| MORGAN STANLEY | ADD | 576,372 | 843,674 | +46.4% | $30.1M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 625,685 | 404,246 | -35.4% | $14.4M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 348,148 | 144,181 | -58.6% | $5.1M | 2025-Q3 |
| UBS Group AG | ADD | 211,600 | 412,015 | +94.7% | $23.7M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 480,691 | 348,148 | -27.6% | $20.1M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 314,466 | 0 | -100.0% | $0.00 | 2025-Q2 |
| MORGAN STANLEY | TRIM | 757,400 | 522,354 | -31.0% | $30.4M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | ADD | 353,716 | 480,691 | +35.9% | $28.0M | 2025-Q1 |
| UBS Group AG | ADD | 154,113 | 211,600 | +37.3% | $12.3M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 145,678 | 82,548 | -43.3% | $4.8M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 278,466 | — | $22.4M | 2024-Q4 |
| UBS Group AG | ADD | 91,494 | 154,113 | +68.4% | $12.4M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 109,417 | 145,678 | +33.1% | $11.7M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 402,565 | — | $32.3M | 2024-Q3 |
5 unique insiders with 9 transactions. Net insider value: $6.7M ($7.2M bought, $508.7K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | SELL | 3,031 | $25.82 | $78.3K |
| Mar 17, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | SELL | 304 | $28.15 | $8.6K |
| Mar 17, 2026 | Waters Kevin | EVP, CFO | SELL | 706 | $28.15 | $19.9K |
| Mar 10, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | SELL | 3,098 | $25.60 | $79.3K |
| Mar 9, 2026 | Desai Antal Rohit | Director | BUY | 43,581 | $24.08 | $1.0M |
| Mar 6, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | SELL | 6,892 | $23.70 | $163.4K |
| Mar 6, 2026 | Desai Antal Rohit | Director | BUY | 106,554 | $23.33 | $2.5M |
| Mar 6, 2026 | Waters Kevin | EVP, CFO | SELL | 6,721 | $23.70 | $159.3K |
| Mar 5, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | A | 29,615 | $0.00 | $0.00 |
| Mar 5, 2026 | PUCKETT DAN | Director | A | 5,476 | $0.00 | $0.00 |
| Mar 5, 2026 | PUCKETT DAN | Director | A | 8,897 | $0.00 | $0.00 |
| Mar 5, 2026 | Waters Kevin | EVP, CFO | A | 47,462 | $0.00 | $0.00 |
| Mar 5, 2026 | Waters Kevin | EVP, CFO | A | 32,576 | $0.00 | $0.00 |
| Mar 5, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | A | 43,811 | $0.00 | $0.00 |
| Mar 5, 2026 | Wood Larry L | President, CEO | A | 127,783 | $0.00 | $0.00 |
| Mar 5, 2026 | Wood Larry L | President, CEO | A | 103,653 | $0.00 | $0.00 |
| Mar 5, 2026 | Desai Antal Rohit | Director | BUY | 142,498 | $25.44 | $3.6M |
| Feb 19, 2026 | Waters Kevin | EVP, CFO | A | 3,532 | $0.00 | $0.00 |
| Feb 19, 2026 | Nouri Alaleh | EVP, CLO, CORP. SEC. | A | 4,872 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 4 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.8/10.
NEUTRAL
CLUSTER
2/10
EVP and CFO Kevin Waters sold $19,876 worth of PRCT shares in a single open-market transaction. The
Mar 19, 2026
BULLISH
CLUSTER
7/10
Over the past week, two executives at PROCEPT BioRobotics sold shares totaling approximately $323,00
Mar 12, 2026
BULLISH
CLUSTER
7/10
A significant insider trading cluster at PRCT shows substantial open-market buying by director Desai
Mar 9, 2026
NEUTRAL
8-K
3/10
Procept BioRobotics appointed Daniel Puckett to its board of directors and audit committee, effectiv
Mar 6, 2026
BULLISH
8-K
8/10
PROCEPT BioRobotics disclosed its 2026 Analyst Day presentation, highlighting strong financial guida
Feb 26, 2026
BULLISH
8-K
8/10
PROCEPT BioRobotics reported Q4 2025 revenue of $76.4 million, up 12% year-over-year, driven by stro
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (71% buy). Based on 21 analysts: 5 strong buy, 10 buy, 5 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$30.44 mean target
+5.8% upside
Buy (2.00)
$20.00 Low
$37.00 High
| Metric | Value |
|---|---|
| Current Price | $28.78 |
| Target Low | $20.00 |
| Target Mean | $30.44 |
| Target Median | $31.00 |
| Target High | $37.00 |
| # Analysts | 9 |
| Recommendation | Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.46 | $-0.49 | $-0.36 | -30.3% | -1.6% | 0↑ 2↓ | $0.1B | 17.6% | 10 |
| Next Q 2026-09-30 |
$-0.34 | $-0.40 | $-0.30 | 11.6% | -0.3% | 1↑ 1↓ | $0.1B | 24.0% | 10 |
| Current FY 2026-12-31 |
$-1.52 | $-1.61 | $-1.43 | 11.9% | -0.1% | 1↑ 1↓ | $0.4B | 29.5% | 10 |
| Next FY 2027-12-31 |
$-0.87 | $-1.23 | $-0.56 | 42.9% | -3.2% | 1↑ 1↓ | $0.5B | 23.3% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.456 | |
| 7d ago | $-0.456 | |
| 30d ago | $-0.449 | -0.007 |
| 60d ago | $-0.408 | -0.048 |
| 90d ago | $-0.397 | -0.059 |
9 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 30, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Mar 6, 2026 | Baird | INITIATE | — | Neutral |
| Mar 2, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Feb 26, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Oppenheimer | DOWNGRADE | Outperform | Perform |
| Feb 26, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 26, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 26, 2026 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Buy | Buy |
| Dec 12, 2025 | UBS | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| May 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| Apr 1, 2026 | 5 | 10 | 5 | 1 | 0 | 71% | |
| Mar 1, 2026 | 5 | 10 | 4 | 1 | 0 | 75% | |
| Feb 1, 2026 | 6 | 10 | 4 | 0 | 0 | 80% | |
| Jan 1, 2026 | 6 | 10 | 4 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 8, 2026
short_volume
Short Volume: PRCT — 68.4% short (0.4M / 0.6M)
Short: 387,740 | Exempt: 1 | TRF Vol: 567,279 | Short Ratio: 68.4% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: PRCT — 59.1% short (0.4M / 0.6M)
Short: 350,518 | Exempt: 215 | TRF Vol: 592,634 | Short Ratio: 59.1% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: PRCT — 72.8% short (0.4M / 0.5M)
Short: 376,465 | Exempt: 1 | TRF Vol: 517,373 | Short Ratio: 72.8% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: PRCT — 57.7% short (0.7M / 1.2M)
Short: 689,171 | Exempt: 288 | TRF Vol: 1,194,320 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: PRCT — 62.6% short (0.8M / 1.3M)
Short: 818,067 | Exempt: 0 | TRF Vol: 1,305,799 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_interest
FTD: PRCT — 22,969 shares ($0.6M) failed to deliver
Settlement: 20260508, Price: $25.44, FTD Value: $584,331.36, PROCEPT BIOROBOTICS CORP COM
May 5, 2026
short_interest
FTD: PRCT — 24,217 shares ($0.6M) failed to deliver
Settlement: 20260505, Price: $24.83, FTD Value: $601,308.11, PROCEPT BIOROBOTICS CORP COM
May 4, 2026
short_interest
FTD: PRCT — 21,387 shares ($0.5M) failed to deliver
Settlement: 20260504, Price: $24.63, FTD Value: $526,761.81, PROCEPT BIOROBOTICS CORP COM
May 4, 2026
short_volume
Short Volume: PRCT — 69.2% short (0.4M / 0.6M)
Short: 414,137 | Exempt: 60 | TRF Vol: 598,153 | Short Ratio: 69.2% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_volume
Short Volume: PRCT — 56.9% short (0.3M / 0.5M)
Short: 285,121 | Exempt: 5 | TRF Vol: 500,856 | Short Ratio: 56.9% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
short_volume
Short Volume: PRCT — 83.2% short (1.6M / 1.9M)
Short: 1,569,154 | Exempt: 0 | TRF Vol: 1,884,892 | Short Ratio: 83.2% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
PRCT Q1 2026 Earnings After Market Close — 2026-04-29
Apr 29, 2026
short_volume
Short Volume: PRCT — 71.4% short (0.7M / 0.9M)
Short: 671,434 | Exempt: 0 | TRF Vol: 940,095 | Short Ratio: 71.4% | Off-exchange volume (dark pool + OTC)
Apr 9, 2026
earnings
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
<p align="left">SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=8Ny1sqVGze7CAed1PfBMyy8e2pg
Mar 27, 2026
short_volume
Short Volume: PRCT — 74.1% short (0.5M / 0.7M)
Short: 487,754 | Exempt: 100 | TRF Vol: 658,038 | Short Ratio: 74.1% | Off-exchange volume (dark pool + OTC)